Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on November 19, 2025. The filing was submitted on November 20, 2025. The Company is a Foreign Private Issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics and Transaction Details
The filing details a share repurchase executed through BNP Paribas SA as part of an existing buyback programme. The following metrics summarize the transaction:
- Date of Purchase: November 19, 2025
- Aggregate Shares Purchased: 243,000 ordinary shares
- Lowest Price Paid: 1,772.50 GBp
- Highest Price Paid: 1,787.00 GBp
- Volume-Weighted Average Price (VWAP): 1,778.18 GBp
- Trading Venues: London Stock Exchange (XLON), CHIX, and BATE
Since the programme announcement on September 30, 2025, the Company has purchased a total of 9,598,000 ordinary shares. Following this transaction, the Company holds 235,062,844 ordinary shares in treasury. The total number of ordinary shares in issue (excluding treasury shares) is 4,080,368,266.
Material Changes and Capital Structure
The purchase reduces the number of shares in issue and increases the treasury share count. The percentage of voting rights attributable to ordinary shares held in treasury is now 5.76%. The total number of voting rights in the Company remains 4,080,368,266. This figure serves as the denominator for shareholders calculating notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing confirms the transaction was effected pursuant to a non-discretionary agreement entered into with the broker on September 30, 2025. The Company includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks and uncertainties described in the "Risk Factors" section of the 2024 Annual Report on Form 20-F and the Q3 Results for 2025. No specific financial guidance or outlook for future periods is provided in this filing.
Investor Verification Checklist
- Verify the total number of shares in issue (4,080,368,266) for calculating ownership thresholds under DTR 5.5.1R.
- Confirm the treasury share percentage (5.76%) for voting rights calculations.
- Review the non-discretionary buyback agreement terms announced on September 30, 2025, to understand the remaining scope of the programme.
- Check the 2024 Form 20-F and Q3 2025 results for detailed risk factors referenced in the cautionary statement.